BioAlliance Pharma announces participation in the SmallCap Event On April 12th and 13th in Paris

BioAlliance Pharma SA (Euronext Paris – BIO), a company dedicated to the treatment and supportive care of cancer and AIDS patients, today announced that it will participate in the SmallCap Event, a forum dedicated to meetings between institutional investors and listed companies from the Euronext Zone, on Monday 12th and Tuesday 13th of April in Paris (Salons Hoche – 9, avenue Hoche).
During these two days, the Management will meet with institutional investors to present BioAlliance Pharma and its development strategy.

1004EN_SmallcapEvent